In recent years, MITA member companies have introduced
innovative technologies to the market, including low-dose
computed tomography (CT), high-intensity focused ultrasound
(HIFU), novel imaging agents, and advanced artificial intelligence
(AI) algorithms. These technologies play an essential role in our
nation’s health care infrastructure and the care pathways of
screening, staging, evaluating, managing, and effectively treating
patients with cancer, heart disease, neurological degeneration,
COVID-19, and numerous other medical conditions.
MITA member products are directly responsible
for nearly 16,000 U.S. jobs, $2 billion in labor
income and $4.2 billion in GDP contribution.*
*Study conducted by FTI Consulting on behalf of the
National Electrical Manufacturers Association, July 2022.